Viatris Investor Can Take Merger Suit Back To State Court
A proposed class action accusing pharmaceutical company Viatris of misleading investors about its plans to pay dividends following its creation in a 2020 merger should not have left state court, a...To view the full article, register now.
Already a subscriber? Click here to view full article